CS logo
small CS logo
LSU Healthcare Network/Saint Charles

New Orleans, Louisiana, United States
Medical center in New Orleans, Louisiana
3700 St Charles Ave, New Orleans, LA 70115

About LSU Healthcare Network/Saint Charles


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at LSU Healthcare Network/Saint Charles


During the past decade, LSU Healthcare Network/Saint Charles conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 9 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "LSU Healthcare Network/Saint Charles" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at LSU Healthcare Network/Saint Charles


According to Clinical.Site data, the most researched conditions in "LSU Healthcare Network/Saint Charles" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "ATM Gene Mutation" (1 trials), "ATR Gene Mutation" (1 trials) and "BARD1 Gene Mutation" (1 trials). Many other conditions were trialed in "LSU Healthcare Network/Saint Charles" in a lesser frequency.

Clinical Trials Intervention Types at LSU Healthcare Network/Saint Charles


Most popular intervention types in "LSU Healthcare Network/Saint Charles" are "Other" (10 trials), "Drug" (8 trials) and "Biological" (5 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (9 trials), "Docetaxel" (4 trials), "Durvalumab" (3 trials), "Erlotinib Hydrochloride" (2 trials) and "FGFR Inhibitor AZD4547" (2 trials). Other intervention names were less common.

Clinical Trials Genders at LSU Healthcare Network/Saint Charles


The vast majority of trials in "LSU Healthcare Network/Saint Charles" are 10 trials for "All" genders.

Clinical Trials Status at LSU Healthcare Network/Saint Charles


Currently, there are NaN active trials in "LSU Healthcare Network/Saint Charles". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in LSU Healthcare Network/Saint Charles, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in LSU Healthcare Network/Saint Charles, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".